Structure Therapeutics Earnings
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.51
Structure Therapeutics earnings summary
Structure Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.51. In its most recent report on Aug 6, 2026 (Q2 2026), GPCR posted EPS of $-0.49. Across the last 14 reports, GPCR shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 6 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
GPCR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.49 | — | +2.6% |
| May 7, 2026 | — | $-0.35 | — | -1.0% |
| Feb 26, 2026 | — | $0.20 | — | -8.3% |
| Nov 6, 2025 | — | $-0.37 | — | +12.1% |
| Aug 6, 2025 | — | $-0.36 | — | +23.4% |
| May 8, 2025 | — | $-0.27 | — | -1.6% |
| Feb 27, 2025 | — | $-0.21 | — | -4.8% |
| Nov 13, 2024 | — | $-0.20 | — | -2.2% |
| Aug 8, 2024 | — | $-0.18 | — | +9.9% |
| May 9, 2024 | — | $-0.19 | — | +0.9% |
| Mar 8, 2024 | — | $-0.15 | — | -4.4% |
| Nov 17, 2023 | — | $-0.21 | — | -4.2% |
| Aug 10, 2023 | — | $-0.20 | — | +1.1% |
| May 11, 2023 | — | $-0.25 | — | -8.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.